This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Diabetes
  • /
  • Empagliflozin Treatment Is Associated With Improve...
Journal

Empagliflozin Treatment Is Associated With Improved β-Cell Function in Type 2 Diabetes Mellitus.

Read time: 1 mins
Published:1st Apr 2018
Author: Al Jobori H, Daniele G, Adams J, Cersosimo E, Solis-Herrera C, Triplitt C et al.
Availability: Pay for access, or by subscription
Ref.:J Clin Endocrinol Metab. 2018;103(4):1402-1407.
DOI:10.1210/jc.2017-01838
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest